About

I am an award-winning writer, editor, photographer and designer with more than 30 years of experience in the media. After studying at the University of Leeds, then London and Anglia HEC, I moved to Canada in the 1980s and started out on the radio while also writing for various music and sports publications, and doing freelance photography. I then edited some magazines before working at a science organization, doing communications and editing publications in a programming language called LaTeX that was challenging but exciting.

Following that, I edited a newspaper, spent some time in the US, and then moved back to the UK where I edited a food B2B publication.
I’ve written, and taken photographs for, hundreds of publications around the world, as well as for books, album covers, DVDs, and shot coverage for documentaries. I’ve edited books, written nine of my own, and done redesigns for several publications. And now I’m writing about biotech, as well as creating videos and a weekly podcast.

I’ve done other things, like running an aquarium, teaching photography and drumming (not at the same time), and running football (soccer) refereeing courses.

In what spare time I have, I love spending time with my wife, son and dog, challenging hikes up the Scottish hills (and down again), playing and writing music, watching baseball and soccer, and collecting memorabilia and autographs.

Articles by Jim Cornall

Mucocort signs deal for pain-relieving mouth ulcer treatment

Cuba to receive €46.7M to boost biopharma sector

Everest Medicines gets go-ahead for renal disease drug study

Research identifies new treatment target for CNS injury and neurological disease

Rivus Pharmaceuticals raises $132M for treatment of obesity and cardio-metabolic disorders

ADVERTISEMENT

Emyria starts program with neuroscience drug discovery CRO

National Hemophilia Foundation launches research fund

Swiss scientists reduce resistance of dormant melanoma cells

Promising MND drug slows disease progression

New study shows how prostate cancer may start

NodThera reveals positive results for inflammasome inhibitors

ADVERTISEMENT